Large-scale synthesis, anti-cancer activity in vivo, and mechanism of anti-proliferative activity of 10-methyl-aplog-1, a simplified analog of aplysiatoxin, as an anti-cancer lead.
Yusuke Hanaki; Masayuki Kikumori; Ryo C. Yanagita; Natsuki Hotta; Harukuni Tokuda; Shunsuke Izumi; Satoshi Sakamoto; Hiroshi Handa; Mutusmi Okamura; Shingo Dan; Kazuhiro Irie
The 8th Takeda Science Foundation Symposium of PharmaSciences “Biomolecule-based Medicinal Science: Featuring Mid-Size Drugs” 2016/01